The mitochondrial C16069T polymorphism, not mitochondrial D310 (D-loop) mononucleotide sequence variations, is associated with bladder cancer

Cancer Cell International

Volumn 13, Issue 1, 2013, Pages

  Shakhssalim, Nasser ^a   Houshmand, Massoud ^b,d   Kamalidehghan, Behnam ^c   Faraji, Abolfazl ^d   Sarhangnejad, Reza ^a   Dadgar, Sepideh ^d   Mobaraki, Maryam ^d   Rosli, Rozita ^e   Sanati, Mohammad H ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

^c UNIVERSITY OF MALAYA   (Malaysia)

^d Special Medical Center Iran   (Iran)

^e UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

16069 D Loop mutation; Mitochondrial DNA displacement loop; Urinary bladder neoplasm

Indexed keywords

EID: 84889069839     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-13-120     Document Type: Article

References (39)

1. Suzuki M, Toyooka S, Miyajima K, Iizasa T, Fujisawa T, Bekele NB, Gazdar AF. Alterations in the mitochondrial displacement loop in lung cancers. Clin Cancer Res 2003, 9(15):5636-5641.
2. Yu M, Zhou Y, Shi Y, Ning L, Yang Y, Wei X, Zhang N, Hao X, Niu R. Reduced mitochondrial DNA copy number is correlated with tumor progression and prognosis in Chinese breast cancer patients. IUBMB life 2007, 59(7):450-457. 10.1080/15216540701509955, 17654121.
3. Tomera KM. NMP22 BladderChek Test: point-of-care technology with life-and money-saving potential. Expert Rev Mol Diagn 2004, 4(6):783-794. 10.1586/14737159.4.6.783, 15525221.
4. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin 2008, 58(2):71-96. 10.3322/CA.2007.0010, 18287387.
5. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007, 18(3):581.
6. Shakhssalim N, Hosseini SY, Basiri A, Eshrati B, Mazaheri M, Soleimanirahbar A. Prominent bladder cancer risk factors in Iran. Asian Pac J Cancer Prev 2010, 11:601-606.
7. Ørntoft TF, Wolf H. Molecular alterations in bladder cancer. Urol Res 1998, 26(4):223-233. 10.1007/s002400050050, 9759995.
8. Brandau S, Böhle A. Bladder cancer. Eur Urol 2001, 39(5):491-497. 10.1159/000052494, 11464028.
9. Warburg O. On the origin of cancer cells. Science 1956, 123(3191):309-314. 10.1126/science.123.3191.309, 13298683.
10. Baysal BE, Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, Bosch A, Mey A, Taschner PEM, Rubinstein WS, Myers EN. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 2000, 287(5454):848. 10.1126/science.287.5454.848, 10657297.
11. Gambhir SS. Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2002, 2(9):683-693. 10.1038/nrc882, 12209157.
12. Lima J, Teixeira-Gomes J, Soares P, Máximo V, Honavar M, Williams D, Sobrinho-Simões M. Germline succinate dehydrogenase subunit D mutation segregating with familial non-RET C cell hyperplasia. J Clin Endocrinol Metab 2003, 88(10):4932. 10.1210/jc.2002-030008, 14557476.
13. Clayton DA, Doda JN, Friedberg EC. The absence of a pyrimidine dimer repair mechanism in mammalian mitochondria. Proc Natl Acad Sci 1974, 71(7):2777. 10.1073/pnas.71.7.2777, 388554, 4212385.
14. LeDoux SP, Wilson GL, Beecham EJ, Stevnsner T, Wassermann K, Bohr VA. Repair of mitochondrial DNA after various types of DNA damage in Chinese hamster ovary cells. Carcinogenesis 1992, 13(11):1967. 10.1093/carcin/13.11.1967, 1423864.
15. Croteau DL, Bohr VA. Repair of oxidative damage to nuclear and mitochondrial DNA in mammalian cells. J Biol Chem 1997, 272(41):25409-25412. 10.1074/jbc.272.41.25409, 9325246.
16. Dai JG, Xiao YB, Min JX, Zhang GQ, Yao K, Zhou RJ. Mitochondrial DNA 4977 BP deletion mutations in lung carcinoma. Indian J Cancer 2006, 43(1):20. 10.4103/0019-509X.25771, 16763358.
17. Ye C, Shu XO, Wen W, Pierce L, Courtney R, Gao YT, Zheng W, Cai Q. Quantitative analysis of mitochondrial DNA 4977-bp deletion in sporadic breast cancer and benign breast diseases. Breast Cancer Res Treat 2008, 108(3):427-434. 10.1007/s10549-007-9613-9, 3836503, 17541740.
18. Futyma K, Putowski L, Cybulski M, Miotla P, Rechberger T, Semczuk A. The prevalence of mtDNA4977 deletion in primary human endometrial carcinomas and matched control samples. Oncol Rep 2008, 20(3):683-688.
19. Akouchekian M, Houshmand M, Hemati S, Ansaripour M, Shafa M. High rate of mutation in mitochondrial DNA displacement loop region in human colorectal cancer. Dis Colon Rectum 2009, 52(3):526. 10.1007/DCR.0b013e31819acb99, 19333057.
20. WADA T, TANJI N, OZAWA A, WANG J, SHIMAMOTO K, SAKAYAMA K, YOKOYAMA M. Mitochondrial DNA mutations and 8-hydroxy-2′-deoxyguanosine Content in Japanese patients with urinary bladder and renal cancers. Anticancer Res 2006, 26(5A):3403.
21. Fliss MS, Usadel H, Caballero OL, Wu L, Buta MR, Eleff SM, Jen J, Sidransky D. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 2000, 287(5460):2017. 10.1126/science.287.5460.2017, 10720328.
22. Liu VWS, Wang Y, Yang HJ, Tsang PCK, Ng TY, Wong LC, Nagley P, Ngan H. Mitochondrial DNA variant 16189 T > C is associated with susceptibility to endometrial cancer. Hum Mutat 2003, 22(2):173-174. 10.1002/humu.10244, 12872259.
23. Poulton J, Luan JA, Macaulay V, Hennings S, Mitchell J, Wareham NJ. Type 2 diabetes is associated with a common mitochondrial variant: evidence from a population-based case-control study. Hum Mol Genet 2002, 11(13):1581-1583. 10.1093/hmg/11.13.1581, 12045211.
24. Chinnery P, Elliott H, Patel S, Lambert C, Keers S, Durham S, McCarthy M, Hitman G, Hattersley A, Walker M. Role of the mitochondrial DNA 16184-16193 poly-C tract in type 2 diabetes. Lancet 2005, 366(9497):1650-1651. 10.1016/S0140-6736(05)67492-2, 16271646.
25. Ashtiani ZO, Heidari M, Hasheminasab S-M, Ayati M, Rakhshani N. Mitochondrial D-Loop polymorphism and microsatellite instability in prostate cancer and benign hyperplasia patients. Asian Pac J Cancer Prev 2012, 13:3863-3868. 10.7314/APJCP.2012.13.8.3863, 23098484.
26. Lesina M, Kurkowski MU, Ludes K, Rose-John S, Treiber M, Klöppel G, Yoshimura A, Reindl W, Sipos B, Akira S. Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer. Cancer Cell 2011, 19(4):456-469. 10.1016/j.ccr.2011.03.009, 21481788.
27. Czarnecka AM, Klemba A, Semczuk A, Plak K, Marzec B, Krawczyk T, Kofler B, Golik P, Bartnik E. Common mitochondrial polymorphisms as risk factor for endometrial cancer. Int Arch Med 2009, 2(1):33. 10.1186/1755-7682-2-33, 2775024, 19863780.
28. Rahmani B, Azimi C, Omranipour R, Raoofian R, Zendehdel K, Saee-Rad S, Heidari M. Mutation screening in the mitochondrial D-loop region of tumoral and non-tumoral breast cancer in Iranian patients. Acta Med Iran 2012, 50(7):447-453.
29. Rosson D, Keshgegian AA. Frequent mutations in the mitochondrial control region DNA in breast tissue. Cancer Lett 2004, 215(1):89-94. 10.1016/j.canlet.2004.04.030, 15374637.
30. Seyedhassani SM, Houshmand M, Kalantar SM, Modabber G, Aflatoonian A. No mitochondrial DNA deletions but more D-loop point mutations in repeated pregnancy loss. J Assist Reprod Genet 2010, 27(11):641-648. 10.1007/s10815-010-9435-2, 2995430, 20499271.
31. Mueller EE, Schaier E, Brunner SM, Eder W, Mayr JA, Egger SF, Nischler C, Oberkofler H, Reitsamer HA, Patsch W. Mitochondrial haplogroups and control region polymorphisms in age-related macular degeneration: a case-control study. PLoS One 2012, 7(2):e30874. 10.1371/journal.pone.0030874, 3278404, 22348027.
32. Zhang J, Asin-Cayuela J, Fish J, Michikawa Y, Bonafé M, Olivieri F, Passarino G, De Benedictis G, Franceschi C, Attardi G. Strikingly higher frequency in centenarians and twins of mtDNA mutation causing remodeling of replication origin in leukocytes. Proc Natl Acad Sci 2003, 100(3):1116. 10.1073/pnas.242719399, 298736, 12538859.
33. Kamalidehghan B, Houshmand M, Panahi MSS, Abbaszadegan MR, Ismail P, Shiroudi MB. Tumoral Cell mtDNA 8.9 kb deletion is more common than other deletions in gastric cancer. Arch Med Res 2006, 37(7):848-853. 10.1016/j.arcmed.2006.03.007, 16971224.
34. Kamalidehghan B, Houshmand M, Ismail P, Panahi MSS, Akbari MHH. ΔmtDNA < sup > 4977 is more common in non-tumoral cells from gastric cancer sample. Arch Med Res 2006, 37(6):730-735. 10.1016/j.arcmed.2006.02.005, 16824932.
35. Marchington D, Hartshorne G, Barlow D, Poulton J. Homopolymeric tract heteroplasmy in mtDNA from tissues and single oocytes: support for a genetic bottleneck. Am J Hum Genet 1997, 60(2):408. 1712400, 9012414.
36. Sanchez-Cespedes M, Parrella P, Nomoto S, Cohen D, Xiao Y, Esteller M, Jeronimo C, Jordan RCK, Nicol T, Koch WM. Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors. Cancer Res 2001, 61(19):7015.
37. Schwartz S, Alazzouzi H, Perucho M. Mutational dynamics in human tumors confirm the neutral intrinsic instability of the mitochondrial D-loop poly-cytidine repeat. Genes Chromosomes Cancer 2006, 45(8):770-780. 10.1002/gcc.20340, 16708351.
38. Dakubo GD. Mitochondrial Genetics and Cancer 2010, 14-123. Heidelberg Dordrecht London New York: Springer.
39. Lievre A, Blons H, Houllier A, Laccourreye O, Brasnu D, Beaune P, Laurent-Puig P. Clinicopathological significance of mitochondrial D-Loop mutations in head and neck carcinoma. Br J Cancer 2006, 94(5):692-697. 2361200, 16495928.